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Abstract
The objective of this book chapter is to provide consolidated and updated 
scientific information about the medicinal plants of the Peruvian Amazon, which 
has a great richness of plants; many of these are used in folkloric medicine to 
treat several diseases. Recently, investigations have reported that these medicinal 
plants possess bioactive phytochemicals against several diseases such as diabetes, 
cancer, inflammation, infectious diseases, and several other health problems, thus 
corroborating some ethnopharmacological reports. The mechanism of action for 
selected bioactive phytochemicals was demonstrated at the molecular level as well 
as the metabolic pathways involved in their biosynthesis were described. Due to the 
large gap in scientific information revealed in this review, we formulated a series of 
strategies to close these scientific knowledge gaps and achieve a sustainable exploi-
tation of medicinal plants in the Peruvian Amazon.
Keywords: cancer, diabetes, ethnopharmacological survey, folkloric medicine
1. Introduction
Peru is cataloged as a megadiverse country due to its great diversity of species, 
particularly in plants [1, 2]. This diversity is attributed to the large number of 
eco-regions present in our territory [3], which were originated by their particular 
geologic evolution [4]. The Peruvian Amazon includes a large proportion of this 
richness in plant species, and several are endemic to this region [5, 6]. The diversity, 
however, remains underestimated because until now a complete and updated inven-
tory of plant species is lacking, but some estimates suggest that more than 50% of 
plant species are unknown to science [7, 8].
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Similarly, there are many gaps in the scientific knowledge of medicinal plants 
of the Peruvian Amazon. These gaps are evident at various knowledge levels from 
the inventory of medicinal plants and their taxonomic identification, the bioactive 
phytochemicals produced, the mechanisms of action of the bioactive phytochemi-
cals, and the metabolic pathways involved in the biosynthesis of bioactive phyto-
chemicals. In part, these gaps in the scientific knowledge can be attributed to several 
factors: (1) the ethnopharmaceutical information has been obtained from few ethnic 
groups (probably <10%); (2) the majority of ethnopharmaceutical surveys have 
been focused on plant species to treat protozoal diseases, with particular emphasis 
on malaria and leishmania [9–12]; and (3) the research centers in the Peruvian 
Amazon generally lack trained scientist, laboratory equipment, and standard 
methods to perform bioassays for the discovery of bioactive phytochemicals against 
diabetes, inflammation, hypertension, cancer, infectious diseases (viral, bacterial, 
and fungal), and other health problems. Consequently, it is fundamental to imple-
ment strategies to surpass these limitations and to close these large knowledge gaps.
Parts of the problems mentioned are addressed in this book chapter that 
consists of six topics. The first topic “The diversity of plants in the Peruvian 
Amazon” describes the diversity of species reported for the country and the 
Peruvian Amazon and are mentioned the possible factors involved in light of 
current knowledge. The second topic “Medicinal plants and indigenous people 
in the Peruvian Amazon” highlights information about medicinal plants and 
ethnic groups. Relevant information of the recently elaborated partial database of 
medicinal plants is also discussed. The third topic “Some bioactive phytochemicals 
identified in medicinal plants” presents structures of bioactive phytochemicals 
against cancer, inflammation, diarrhea, malaria, and diabetes. The fourth topic 
“Mechanism of action of select bioactive phytochemicals” explains the molecular 
bases of the mechanisms of action of well-characterized phytochemicals such 
as taspine, crofelemer, mitraphylline, quercetin, linalool, and bixin. The fifth 
topic “Biosynthetic pathways for relevant bioactive phytochemicals” describes 
and provides graphically key metabolic pathways involved in the biosynthesis 
of quercetin, linalool, and bixin. The final topic “Strategies for the sustainable 
use of medicinal plants” recommends the adoption of strategies to accelerate the 
generation of scientific knowledge that permits a sustainable exploitation of the 
medicinal plants in the Peruvian Amazon.
2. The diversity of plants in the Peruvian Amazon
The plant diversity in the Amazonian lowland rain forest is astounding. This 
diversity was recently demonstrated with a large-scale taxonomic inventory, 
which identified 14,003 species; 1788 genera; and 188 families of seed plants, 
in which 50% of these species can reach ≥10 cm stem diameter at breast height 
(DBH). More than 52% of seed plant species diversity in this region include 
shrubs, small trees, lianas, vines, and herbs [1]. The Peruvian Amazon includes 
~39% (5401 species) of these species. Also, a previous study showed that a forest 
near to Iquitos is the most species-rich in the world, with ~300 species ≥10 cm in 
DBH [2]. In addition, it is estimated that ~17,143 plant species are circumscribed 
within the national boundaries [13], and approximately 13% of these plant spe-
cies are endemic to the Peruvian Amazon [5, 6]. It is speculated, however, that 
only 60% of the Peruvian flora has been identified [7]. Consequently, Peru is 
considered to be one of the 17 megadiverse countries, a global center for species 
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richness of plants and other organisms [14]. This peculiarity is attributed to the 
most Holdridge life zones (containing 84 of the 107 eco-regions of the world) 
that possess our country [3], which was determined for their particular geologic 
evolution [4].
3. Medicinal plants and indigenous people in the Peruvian Amazon
The Amazon lowland rain forest provides multiple benefits to its inhabitants 
[15]. According to Schultes [16], rain forests have an incalculable value as an 
untapped emporium of germplasm for new commercial plants. For example, to 
the inhabitants of Mishana (a community near Iquitos), the tropical forest pro-
vides timber resources (e.g., sawlogs and pulpwood) and several forest products 
such as edible fruits, oils, latex, fiber, and medicines. The yield of these forest 
products is provided by 72 species (26.2%) that are sold in the Iquitos market 
[17]. In addition, it is estimated that ~4400 native plant species of the Peruvian 
flora are used by inhabitants for 49 different applications [18]. With reference to 
bioactive plants, it was reported that more than 1300 species are used by natives 
in the northwest Amazon as medicines, poisons, or narcotics [16]. To date, 
however, the list of medicinal plants useful for the discovery and development 
Figure 1. 
Families of medicinal plants (A) and number of their uses (B) to treat diseases in the Peruvian Amazon.
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of drugs is fragmentary and incomplete, because the ethnopharmacological 
surveys conducted in the Peruvian Amazon are sporadic and scarce. Recently, 
we elaborated a partial database of medicinal plants of the Peruvian Amazon, 
which is based on the few available ethnobotanical studies [9–12, 19–25], one list 
of the Research Institute of The Peruvian Amazon (IIAP) and surveys carried 
out by our research group in the Pasaje Paquito (the main center for commercial-
ization of medicinal plants in the Loreto region, Iquitos). The medicinal plant 
database includes 1410 species belonging to 157 plant families; these taxonomic 
assignations were verified with the Plant List database (http://www.theplantlist.
org/). Of these, the top 10 families by number of medicinal plant species are 
Fabaceae (137), Asteraceae (80), Rubiaceae (57), Araceae (53), Piperaceae (51), 
Solanaceae (51), Euphorbiaceae (47), Apocynaceae (39), Bignoniaceae (39), and 
Clusiaceae (32). In addition, this database reveals that the plant families with 
the highest number of medicinal uses are Fabaceae (272), Asteraceae (244), 
Rubiaceae (197), Euphorbiaceae (180), Piperaceae (179), and Solanaceae with 
166 medicinal uses (Figure 1).
It is paradoxical that only some ethnic groups were evaluated to date for ethno-
pharmacological surveys, given the Peruvian Amazon’s ethnic diversity (Figure 2). 
According to a recent national census, the indigenous population of the Peruvian 
Amazon consists of 332,975 inhabitants that include 13 linguistic families that are 
grouped into 51 ethnic groups. Of the total number of communities registered, 
21 are polyethnic [26, 27]. In all these ethnic groups, the millenary knowledge of 
medicinal plants used to combat common diseases is a fundamental component 
within the indigenous health systems, which has been maintained from generation 
to generation. However, due to the transculturation by modernization and global-
ization, this ancestral knowledge is being lost [15]. Consequently, it is necessary 
to implement strategies to preserve this invaluable knowledge for the benefit of 
humankind.
4. Some bioactive phytochemicals identified in medicinal plants
Presently, the list of medicinal plants of the Peruvian Amazon is partial; in 
consequence, only for the most known plants were identified a few bioactive 
phytochemicals (Figure 3). There is no way to estimate how many new biochemi-
cal structures, probably of great value to humankind, remain undiscovered in the 
Peruvian Amazon. Some of the phytochemicals isolated and with corroborated 
bioactivity against cancer [28], inflammation [29], diarrhea [30], malaria [31], 
diabetes [32], and several other diseases were determined [33].
Figure 2. 
Selected ethnic groups from the Peruvian Amazon.
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5. Mechanism of action of select bioactive phytochemicals
5.1 Bixin
Bixin constitutes the main pigment of the industrial annatto obtained from the 
seed coat of Bixa orellana [34]. This phytochemical belongs to the relatively small fam-
ily of apocarotenoids; it was the first cis-carotenoid to be isolated from natural sources 
[35]. However, it was not until 1961 that its chemical structure and stereochemistry 
were determined through nuclear magnetic resonance spectroscopy studies [36].
This phytochemical compound shows pleiotropic bioactivities with health-
promoting properties. It was recently demonstrated that bixin caused arrest of 
Hep3B cell line at G2/M checkpoint of the cell cycle and the molecular mechanism 
of action was demonstrated by a modeling study, which was based in the favorable 
Figure 3. 
A small selection of bioactive phytochemicals identified in medicinal plants of the Peruvian Amazon.
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binding of bixin to domains of Bax BH3 and FasL proteins [37]. Consequently, 
bixin should be used for developing agents to combat human hepatocellular car-
cinoma. Bixin is also a potent activator of the transcription factor nuclear factor 
erythroid 2-related factor 2 (NRF2), which is the master regulator of the cellular 
antioxidant response protecting the skin against various environmental stressors 
including UV radiation and electrophilic pollutants [38–40]. The protective effects 
against solar UV-induced skin damage are due to the NRF2-dependence of bixin-
induced antioxidant and anti-inflammatory effects [39]. In addition, bixin displays 
molecular activities as antioxidant, excited-state quencher, peroxisome proliferator-
activated receptor α/γ agonist, and Toll-like receptor 4/nuclear factor kappa-light-
chain-enhancer of activated B-cell antagonist. Together, these bioactivities may be 
important to the improvement of skin barrier function and environmental stress 
protection [40].
5.2 Crofelemer
Crofelemer previously known as SP-303 is a large proanthocyanidin oligomer 
isolated from the bark latex of the plant Croton lechleri Müll. Arg. [41]. Initial 
studies have demonstrated the immense antiviral activity of crofelemer against 
a gamma of DNA and RNA viruses such as respiratory syncytial virus, influenza 
A virus, parainfluenza virus, herpesvirus types 1 and 2, and hepatitis A and B 
viruses. The antiviral mechanism implies the direct interaction of crofelemer to 
components of the viral envelope, blocking both the viral attachment and the cell 
invasion [41]. More recently, crofelemer is used as a first-in-class antidiarrheal 
medication, and its efficacy has been investigated in vivo assays [42] and in patients 
with HIV-associated diarrhea, diarrhea of various infectious etiologies, as well as 
diarrhea-predominant irritable bowel syndrome [43]. Crofelemer was recently 
approved by the FDA to treat diarrhea in HIV/AIDS patients on antiretroviral 
therapy [44].
The mechanism of action as antidiarrheal of this proanthocyanidin oligomer 
consists in the dual inhibitory action on two structurally unrelated prosecretory 
intestinal Cl− channels, which are responsible for chloride secretion and subse-
quent luminal hydration. The first target is an extracellular site of the cystic fibrosis 
transmembrane regulator (CFTR) Cl− channel (∼60%, IC50 ∼ 7 μM), which 
produces a voltage-independent block with stabilization of the channel closed state. 
The second target is the intestinal calcium-activated Cl− channel (CaCC) by a 
voltage-independent inhibition mechanism (>90%, IC50 ∼ 6.5 μM) [45].
5.3 Linalool
An abundant (~90%) essential oil of the leaves of Aniba rosaeodora [46, 47] that is 
used in the traditional medicine of the Peruvian and Brazilian Amazon for its effects 
on the central nervous system, such as sedative, anticonvulsant, and antidepressant 
[19, 47, 48]. Additionally, linalool has anti-inflammatory [49], anticancer [50–52], 
antihyperlipidemic, antinociceptive, analgesic, anxiolytic, and neuroprotective 
properties [53]. Several studies have demonstrated a gamma of anti-infectious activity 
like antiviral [54], antibacterial [55–57], antifungal [58, 59], and antileishmanial [55, 
60, 61].
The anticancer mechanisms of action of linalool in hepatocellular carcinoma 
(HCC) HepG2 cells were recently revealed by Rodenak-Kladniew et al. [50] 
(Figure 4). According to these researchers,  linalool in a dose-dependently blocked 
cell proliferation by inducing G0/G1 cell cycle arrest, through Cdk4 and cyclin 
A downregulation, p21 and p27 upregulation, and apoptosis, characterized by 
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mitochondrial membrane potential loss, caspase-3 activation, poly(ADP-ribose) 
polymerase cleavage, and DNA fragmentation
5.4 Mitraphylline
A pentacyclic oxindolic alkaloid that was isolated from the alkaloid fraction of 
the dried inner bark of Uncaria tomentosa (Willd. ex Schult.) DC; it represents the 
most abundant phytochemical (40%) of the alkaloid fraction [62]. Several investi-
gations have demonstrated the immunoregulatory activity of this compound or the 
pentacyclic oxindolic alkaloid-enriched fraction [63–67].
The mechanism of action as immunoregulator of mitraphylline consists in 
both to protect cells against oxidative stress and to elicit a response via an NF-kβ-
dependent mechanism. The first mechanism is based on the inhibition of the 
inducible nitric oxide synthase gene expression; consequently, nitrite formation 
and programmed cell death are avoided. Finally, in the second mechanism, the 
inhibition of NF-kβ signaling permits the abrogation of the release of pro-inflam-
matory cytokines such as TNFα, IL-6, IL-1 α, IL-1β, IL-4, IL-17, and IFN-α [63–67].
5.5 Quercetin
A polyphenol categorized as a flavonol, one of the five subclasses of flavonoid 
compounds. This bioactive phytochemical is biosynthesized and accumulated in 
Figure 4. 
Anticancer mechanisms of action of linalool in hepatocellular carcinoma (HCC) HepG2 cells.
Pharmacognosy - Medicinal Plants
8
tissues and organs of several medicinal plants of the Peruvian Amazon such as 
Annona montana, Bauhinia longifolia, Bertholletia excelsa, Genipa americana, Inga 
edulis, Mauritia flexuosa, Myrciaria dubia, Oenocarpus bataua, Solanum sessiliflorum, 
Theobroma bicolor, T. cacao, and T. grandiflorum [68–70]. Quercetin exhibits mul-
tifaceted therapeutic applications for multiplicity of unrelated acute and chronic 
human ailments like allergy, arthritis, asthma, bacterial and viral infections, cancer, 
cardiovascular diseases, inflammation, obesity, diabetes, mood disorders, neuropa-
thologies, and other health problems [71–76].
This multiple health beneficial properties of quercetin are attributed to their 
particular mechanism of action based on inhibition of several key proteins and 
enzymes (Figure 5). For example, a recent research showed that this compound is a 
potent inhibitor of 25 human serine/threonine kinases [77]. The multitarget inhibitor 
explains its beneficial pleiotropic effects on humans. This flavonoid-type inhibitor is 
effective against xanthine oxidase, appropriate for the treatment of hyperuricemia, 
gout, and inflammatory disease states. The inhibitory mechanism is based on the 
favorable steric complementarity of the conjugated three-ring structure of quercetin 
with the active site of xanthine oxidase. The enzyme-quercetin binary complex is 
stabilized by van der Waals forces and hydrogen-bonding interactions with both  
binding and catalytic amino acid residues, respectively [78, 79]. Recently, Hamilton  
et al. [80] have demonstrated that quercetin is a competitive inhibitor of glucose 
uptake by GLUT1. These researchers showed that the inhibitory effect is simply by 
binding of quercetin to the surface of GLUT1 [80]. Finally, several structural stud-
ies by X-ray diffraction have corroborated the inhibitory complex of quercetin with 
several human protein kinases [81–83].
5.6 Taspine
An alkaloid isolated for the first time by Vaisberg et al. [84] from the bark latex 
of the plant species Croton lechleri Müll. Arg. Previous in vitro and in vivo investiga-
tions have demonstrated that taspine promotes early phases of wound healing in 
a dose-dependent manner [84, 85]. Taspine was also demonstrated to activate the 
pro-apoptotic cascade, which oligomerizes Bak/Bax into pores that result in the 
release of cytochrome c and consequently apoptosis in HCT116 colon carcinoma 
cells [86]. Similar results were reported for an in vivo study conducted with ZR-75-
30 human breast cancer xenografts in athymic mice [87].
The mechanism of action of taspine as a topoisomerase inhibitor was revealed 
recently. Initially, using in vitro assays, Fayad et al. [86] observed the inhibition 
of both topoisomerases I and II by taspine. Castelli et al. [88] corroborated the 
Figure 5. 
Inhibitory complex of quercetin with selected human kinase targets.
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inhibitory action of taspine on purified topoisomerase I and provided the molecular 
details of the inhibitory action. These researchers showed that taspine inhibits the 
catalytic process (cleavage and religation), and molecular docking simulations 
showed that the formation of the complex enzyme-taspine is accomplished by 
the interaction in the proximity of the active site preventing the cleavage reac-
tion. While, that the religation inhibition is explained by DNA intercalation of the 
inhibitor with the enzyme-DNA-binary complex.
6. Biosynthetic pathways for relevant bioactive phytochemicals
6.1 Bixin biosynthesis
The biosynthesis of the apocarotenoid ester bixin from lycopene requires four 
enzymatic reactions (Figure 6). The first enzymatic reaction of bixin biosynthesis 
is the 5-6/5′-6′ oxidative cleavage of lycopene catalyzed by lycopene cleavage 
oxygenase to produce two sulcatone and one bixin aldehyde molecule. The second 
enzymatic reaction is the oxidative conversion of aldehyde into carboxylic acid 
groups in bixin aldehyde to produce norbixin by bixin aldehyde dehydrogenase. 
The third enzymatic reaction is the methylation of one norbixin carboxyl group 
to produce bixin by norbixin methyltransferase. This enzyme utilizes S-adenosyl-
l-methionine as a methyl-group donor. Finally, the last biochemical reaction is 
the methylation of one bixin carboxyl group to produce bixin dimethyl ester by 
bixin methyltransferase, using S-adenosyl-l-methionine as methyl-group donor 
[89–91].
6.2 Linalool biosynthesis
The fundamental building blocks in plants for terpenoid production, i.e., 
isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), are 
generated via two independent pathways, namely, 2-C-methyl-d-erythritol 
4-phosphate (MEP) pathway and the mevalonate acid (MVA) pathway [92, 93]. 
The plastid terpenes are formed exclusively via the MEP pathway; however, sterols 
are biosynthesized via MVA pathway in the cytoplasm and mitochondria [94, 95]. 
Radiolabeling studies in the early 1970s showed that in Cinnamomum camphora the 
biosynthesis of linalool is accomplished via the MVA pathway [96]. Nevertheless, 
recent transcriptome analysis of leaves in two chemotypes of C. camphora showed 
that both pathways provide the biosynthetic precursors IPP and DMAPP for the 
main monoterpenes (i.e., linalool and borneol) synthesis [97]. The balance of IPP/
DMAPP is controlled by type 1 and type 2 isopentenyl diphosphate:dimethylallyl 
diphosphate isomerase, which reversibly converts IPP to DMAPP [98, 99]. Further, 
IPP and DMAPP are condensed by geranyl diphosphate synthase and isopentenyl 
diphosphate to produce geranyl diphosphate by geranyl diphosphate synthase. 
Finally, geranyl diphosphate is transformed in linalool by the action of linalool 
synthase (Figure 7).
6.3 Quercetin biosynthesis
A bioactive phytochemical that is biosynthesized through the phenylpropanoid 
pathway [100]. The initial reactions transform phenylalanine into 4-coumaroyl-
CoA, which enters into the flavonoid biosynthesis pathway (Figure 8). The first 
committed enzyme in the flavonoid pathway, chalcone synthase, uses malonyl-CoA 
and 4-coumaroyl-CoA as substrates to produce naringenin chalcone. This metabolic 
Pharmacognosy - Medicinal Plants
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intermediary is converted to (+)-dihydrokaempferol by the action of two enzymes, 
one isomerase and one dioxygenase, respectively. Next, (+)-dihydrokaempferol 
quercetin is biosynthesized by two alternative and consecutive enzymatic reac-
tions: first, enzymes (+)-dihydrokaempferol 3′-hydroxylase and quercetin synthase 
produce (+)-taxifolin as a metabolic intermediary, and, second, enzymes dihy-
drokaempferol synthase and kaempferol monooxygenase produce kaempferol as a 
metabolic intermediary [101].
Figure 6. 
Biosynthetic pathway for bixin.
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7. Strategies for the sustainable use of medicinal plants
To date, the research contributions of the Peruvian Amazon to ethnophar-
macology have been very limited, and data are still fragmentary and dispersed. 
Consequently, to ensure a sustainable economic development, we need to obtain 
a competitive advantage based on our medicinal plant resources. To achieve these 
goals, we must formulate appropriate strategies based on solid scientific knowledge. 
First, we need to record the millenary knowledge of folk medicine practiced by the 
total ethnic groups of the Peruvian Amazon. Second, based on this information, we 
Figure 7. 
Biosynthetic pathway for linalool through the MEP pathway.
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should construct a complete catalog of known medicinal plants with correct taxo-
nomic identifications. Third, an enriched germplasm bank of medicinal plants should 
be established with accessions of several sites of the Peruvian Amazon. Fourth, 
the bioactivity of extracts/bio-guided isolated and purified phytochemicals with a 
battery of in vitro and in vivo standardized bioassays against multiple diseases (e.g., 
diabetes, cancer, bacterial infections, etc.) should be established. Fifth, multiomics 
approaches such as genomics, transcriptomics, proteomics, and metabolomics should 
be performed to identify key genes, enzymes, and metabolic pathways responsible 
for the biosynthesis of promising bioactive phytochemicals. Sixth, in the short term, 
a web-based computerized database to facilitate storage, management, transfer and 
Figure 8. 
Biosynthetic pathway for quercetin.
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exchange, and analysis of the data by researchers, planners, and other interested 
users should be developed and made freely available. Finally, the availability of this 
basic scientific information could support the development of genetic improvement 
programs for medicinal plants and allow a boost of biotechnological applications, 
based on synthetic biology tools and using bacterial, microalgal, and several other 
cell-/tissue-based platforms for the production of phytochemical compounds of 
interest, thus preventing overexploitation and species extinction of medicinal plants.
8. Conclusions
The Peruvian Amazon houses multiple medicinal plants, but the species catalog 
is still incomplete, because ethnopharmaceutical studies are lacking in the great 
majority of ethnic groups. A select number of medicinal plant species, however, 
have been identified as a potentially useful source of bioactive phytochemical 
compounds to treat various diseases such as diabetes, cancer, inflammation, and 
infections caused by pathogens, among other health problems. Also, for some of 
these bioactive phytochemical compounds, the mechanisms of action are known, 
which are characterized by presenting a common pattern, their pleiotropic effects, 
which is attributable to act on multiple targets, consequently, affecting various cel-
lular processes. In relation to the metabolic pathways responsible for biosynthesis of 
these molecules, only very few are known, but for the vast majority of phytochemi-
cals, it remains a great mystery that needs to be clarified. Therefore, we formulated 
a series of strategies to close these scientific knowledge gaps and achieve a sustain-
able exploitation of medicinal plants in the Peruvian Amazon.
Acknowledgements
This research was supported by grants from Universidad Nacional de la 
Amazonía Peruana (UNAP). We also thank and especially dedicate this chapter 
book to Janeth Braga Vela, who is a great professor and guide and an exceptional and 
inspiring woman.
Conflict of interest
The authors declare no conflict of interest.
Pharmacognosy - Medicinal Plants
14
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Author details
Juan Carlos Castro1*, Joseph Dylan Maddox2,3, Marianela Cobos4, Jae Diana Paredes4, 
Anthony Jhoao Fasabi1, Gabriel Vargas-Arana5,6, Jorge Luis Marapara1, Pedro 
Marcelino Adrianzen1, María Zadith Casuso4 and Segundo Levi Estela4
1 Specialized Unit of Biotechnology, Research Center of Natural Resources of the 
Amazon (CIRNA), National University of the Peruvian Amazon (UNAP), Iquitos, 
Peru
2 Pritzker Laboratory for Molecular Systematics and Evolution, The Field Museum 
of Natural History, Chicago, IL, USA
3 Environmental Sciences, American Public University System, Charles Town, WV, 
USA
4 Laboratory of Biotechnology and Bioenergetics, Scientific University of Peru 
(UCP), Iquitos, Peru
5 Laboratory of Natural Products Chemistry, Research Institute of the Peruvian 
Amazon (IIAP), Iquitos, Peru
6 Peruvian University of the East (UPO), Iquitos, Peru
*Address all correspondence to: juan.castro@unapiquitos.edu.pe
15
Medicinal Plants of the Peruvian Amazon: Bioactive Phytochemicals, Mechanisms of Action…
DOI: http://dx.doi.org/10.5772/intechopen.82461
References
[1] Cardoso D, Särkinen T, Alexander 
S, Amorim AM, Bittrich V, Celis M, 
et al. Amazon plant diversity revealed 
by a taxonomically verified species list. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2017;114:10695-10700. DOI: 
10.1073/pnas.1706756114
[2] Gentry AH. Tree species richness of 
upper Amazonian forests. Proceedings of 
the National Academy of Sciences of the 
United States of America. 1988;85:156-
159. DOI: 10.1073/pnas.85.1.156
[3] Holdridge LR. Life Zone Ecology. Costa 
Rica. Tropical Science Center; 1967. 206 p
[4] Hoorn C, Wesselingh FP, ter Steege 
H, Bermudez MA, Mora A, Sevink J, 
et al. Amazonia through time: Andean 
uplift, climate change, landscape 
evolution, and biodiversity. Science. 
2010;330:927-931. DOI: 10.1126/
science.1194585
[5] Rodríguez LO, Young KR. Biological 
diversity of Peru: Determining 
priority areas for conservation. 
Ambio: A Journal of the Human 
Environment. 2000;29:329-337. DOI: 
10.1579/0044-7447-29.6.329
[6] van der Werff H, Consiglio T. 
Distribution and conservation 
significance of endemic species 
of flowering plants in Peru. 
Biodiversity and Conservation. 
2004;13:1699-1713. DOI: 
10.1023/B:BIOC.0000029334.69717.f0
[7] Brack A. Perú: Biodiversidad, 
pobreza y bionegocios. Lima, Perú: 
Programa de las Naciones Unidas para el 
Desarrollo; 2004
[8] Joppa LN, Roberts DL, Myers N, 
Pimm SL. Biodiversity hotspots house 
most undiscovered plant species. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2011;108:13171-13176. DOI: 
10.1073/pnas.1109389108
[9] Céline V, Adriana P, Eric D, Joaquina 
A, Yannick E, Augusto LF, et al. 
Medicinal plants from the Yanesha 
(Peru): Evaluation of the leishmanicidal 
and antimalarial activity of selected 
extracts. Journal of Ethnopharmacology. 
2009;123:413-422. DOI: 10.1016/j.
jep.2009.03.041
[10] Ruiz L, Ruiz L, Maco M, Cobos M, 
Gutierrez-Choquevilca A-L, Roumy 
V. Plants used by native Amazonian 
groups from the Nanay River (Peru) 
for the treatment of malaria. Journal of 
Ethnopharmacology. 2011;133:917-921. 
DOI: 10.1016/j.jep.2010.10.039
[11] Vásquez-Ocmín P, Cojean S, 
Rengifo E, Suyyagh-Albouz S, 
Amasifuen Guerra CA, Pomel S, 
et al. Antiprotozoal activity of 
medicinal plants used by Iquitos-Nauta 
road communities in Loreto (Peru). 
Journal of Ethnopharmacology. 
2018;210:372-385. DOI: 10.1016/j.
jep.2017.08.039
[12] Estevez Y, Castillo D, Pisango 
MT, Arevalo J, Rojas R, Alban J, et al. 
Evaluation of the leishmanicidal 
activity of plants used by Peruvian 
Chayahuita ethnic group. Journal of 
Ethnopharmacology. 2007;114:254-259. 
DOI: 10.1016/j.jep.2007.08.007
[13] Brako L, Zarucchi JL. Catalogue of 
the Flowering Plants and Gymnosperms 
of Peru. 6th ed. St. Louis, Mo: Missouri 
Botanical Garden; 1993. 1286 p
[14] Mittermeier RA, Mittermeier CG. 
Megadiversity: Earth’s Biologically 
Wealthiest Nations. CEMEX; 1997. 501 p
[15] Bennett BC. Plants and people 
of the Amazonian rainforests. 
Bioscience. 1992;42:599-607. DOI: 
10.2307/1311925
Pharmacognosy - Medicinal Plants
16
[16] Schultes RE. The Amazonia as 
a source of new economic plants. 
Economic Botany. 1979;33:259-266. 
DOI: 10.1007/BF02858251
[17] Peters CM, Gentry AH, Mendelsohn 
RO. Valuation of an Amazonian 
rainforest. Nature. 1989;339:655-656. 
DOI: 10.1038/339655a0
[18] Brack A. Diccionario enciclopédico 
de plantas útiles del Perú. Lima, Perú: 
Programa de las Naciones Unidas para el 
Desarrollo; 1999
[19] Mejía K, Rengifo E, Vila C. Plantas 
Medicinales de uso popular en la 
Amazonía Peruana. Iquitos, Perú: 
Agencia Española de Cooperación 
Internacional (AECI), Instituto 
de Investigaciones de la Amazonía 
Peruana; 2000
[20] Sanz-Biset J, Campos-de-la-Cruz J, 
Epiquién-Rivera MA, Cañigueral S. A 
first survey on the medicinal plants of 
the Chazuta valley (Peruvian Amazon). 
Journal of Ethnopharmacology. 
2009;122:333-362. DOI: 10.1016/j.
jep.2008.12.009
[21] Odonne G, Valadeau C, Alban-
Castillo J, Stien D, Sauvain M, 
Bourdy G. Medical ethnobotany of 
the Chayahuita of the Paranapura 
basin (Peruvian Amazon). Journal of 
Ethnopharmacology. 2013;146:127-153. 
DOI: 10.1016/j.jep.2012.12.014
[22] Odonne G, Bourdy G, Castillo 
D, Estevez Y, Lancha-Tangoa A, 
Alban-Castillo J, et al. Ta’ta’, Huayani: 
Perception of leishmaniasis and 
evaluation of medicinal plants used by 
the Chayahuita in Peru. Part II. Journal 
of Ethnopharmacology. 2009;126:149-
158. DOI: 10.1016/j.jep.2009.07.015
[23] Valadeau C, Castillo JA, Sauvain M, 
Lores AF, Bourdy G. The rainbow hurts 
my skin: Medicinal concepts and plants 
uses among the Yanesha (Amuesha), 
an Amazonian Peruvian ethnic group. 
Journal of Ethnopharmacology. 
2010;127:175-192. DOI: 10.1016/j.
jep.2009.09.024
[24] Sanz-Biset J, Cañigueral S. Plants 
as medicinal stressors, the case of 
depurative practices in Chazuta valley 
(Peruvian Amazonia). Journal of 
Ethnopharmacology. 2013;145:67-76. 
DOI: 10.1016/j.jep.2012.09.053
[25] Rainer WB, Douglas S. Medicinal 
Plants of the Andes and the Amazon: 
The Magic and Medicinal Flora of 
Northern Peru. Trujillo, Perú: William 
L. Brown Center; 2015. 292 p
[26] ¿Qué es la BDPI? Base de Datos 
de Pueblos Indígenas u Originarios. 
Available from: http://bdpi.cultura.gob.
pe/ [Accessed: October 23, 2018]
[27] Perú Instituto Nacional de 
Estadística e Informática. Available 
from: https://www.inei.gob.pe/ 
[Accessed: October 23, 2018]
[28] Wang S-C, Lu M-C, Chen H-L, 
Tseng H-I, Ke Y-Y, Wu Y-C, et al. 
Cytotoxicity of calotropin is through 
caspase activation and downregulation 
of anti-apoptotic proteins in K562 
cells. Cell Biology International. 
2009;33:1230-1236. DOI: 10.1016/j.
cellbi.2009.08.013
[29] Junyuan Z, Hui X, Chunlan 
H, Junjie F, Qixiang M, Yingying 
L, et al. Quercetin protects against 
intestinal barrier disruption 
and inflammation in acute 
necrotizing pancreatitis through 
TLR4/MyD88/p38 MAPK and 
ERS inhibition. Pancreatology. 
2018;18:742-752. DOI: 10.1016/j.
pan.2018.08.001
[30] Van Sebille YZA, Gibson RJ, 
Wardill HR, Ball IA, Keefe DMK, 
Bowen JM. Dacomitinib-induced 
diarrhea: Targeting chloride secretion 
17
Medicinal Plants of the Peruvian Amazon: Bioactive Phytochemicals, Mechanisms of Action…
DOI: http://dx.doi.org/10.5772/intechopen.82461
with crofelemer. International Journal 
of Cancer. 2018;142:369-380. DOI: 
10.1002/ijc.31048
[31] Sá MS, de Menezes MN, Krettli AU, 
Ribeiro IM, Tomassini TCB, Ribeiro dos 
Santos R, et al. Antimalarial activity 
of physalins B, D, F, and G. Journal of 
Natural Products. 2011;74:2269-2272. 
DOI: 10.1021/np200260f
[32] Wang H-Y, Kan W-C, Cheng T-J, Yu 
S-H, Chang L-H, Chuu J-J. Differential 
anti-diabetic effects and mechanism 
of action of charantin-rich extract 
of Taiwanese Momordica charantia 
between type 1 and type 2 diabetic 
mice. Food and Chemical Toxicology. 
2014;69:347-356. DOI: 10.1016/j.
fct.2014.04.008
[33] Kaneshima T, Myoda T, Toeda K, 
Fujimori T, Nishizawa M. Antimicrobial 
constituents of peel and seeds of 
camu-camu (Myrciaria dubia). 
Bioscience, Biotechnology, and 
Biochemistry. 2017;81:1461-1465. DOI: 
10.1080/09168451.2017.1320517
[34] Zechmeister L. Cis-trans 
isomerization and stereochemistry of 
carotenoids and diphenyl-polyenes. 
Chemical Reviews. 1944;34:267-344. 
DOI: 10.1021/cr60108a004
[35] Karrer P, Helfenstein A, 
Widmer R, van Itallie TB. Über 
Bixin. (XIII. Mitteilung über 
Pflanzenfarbstoffe.). Helvetica Chimica 
Acta. 1929;12:741-756. DOI: 10.1002/
hlca.19290120174
[36] Barber MS, Hardisson A, 
Jackman LM, Weedon BCL. Studies 
in nuclear magnetic resonance. Part 
IV. Stereochemistry of the bixins. 
Journal of the Chemical Society. 
1961;0:1625-1630. DOI: 10.1039/
JR9610001625
[37] Kumar Y, Phaniendra A, Periyasamy 
L. Bixin triggers apoptosis of human 
Hep3B hepatocellular carcinoma 
cells: An insight to molecular 
and in silico approach. Nutrition 
and Cancer. 2018;70:1-13. DOI: 
10.1080/01635581.2018.1490445
[38] Rojo de la Vega M, Zhang DD, 
Wondrak GT. Topical bixin confers 
NRF2-dependent protection against 
photodamage and hair graying in 
mouse skin. Frontiers in Pharmacology. 
2018;9:287. DOI: 10.3389/
fphar.2018.00287
[39] Tao S, Park SL, Rojo de la Vega M, 
Zhang DD, Wondrak GT. Systemic 
administration of the apocarotenoid 
bixin protects skin against solar 
UV-induced damage through activation 
of NRF2. Free Radical Biology and 
Medicine. 2015;89:690-700. DOI: 
10.1016/j.freeradbiomed.2015.08.028
[40] Rojo de la Vega M, Krajisnik A, 
Zhang D, Wondrak G, Rojo de la Vega 
M, Krajisnik A, et al. Targeting NRF2 
for improved skin barrier function 
and photoprotection: Focus on the 
achiote-derived apocarotenoid bixin. 
Nutrients. 2017;9:1371. DOI: 10.3390/
nu9121371
[41] Ubillas R, Jolad SD, Bruening 
RC, Kernan MR, King SR, Sesin DF, 
et al. SP-303, an antiviral oligomeric 
proanthocyanidin from the latex of 
Croton lechleri (Sangre de Drago). 
Phytomedicine. 1994;1:77-106. DOI: 
10.1016/S0944-7113(11)80026-7
[42] Gabriel SE, Davenport SE, Steagall 
RJ, Vimal V, Carlson T, Rozhon EJ. A 
novel plant-derived inhibitor of cAMP-
mediated fluid and chloride secretion. 
American Journal of Physiology. 
1999;276:G58-G63
[43] Cottreau J, Tucker A, Crutchley R, 
Garey KW. Crofelemer for the treatment 
of secretory diarrhea. Expert Review 
of Gastroenterology & Hepatology. 
2012;6:17-23. DOI: 10.1586/egh.11.87
Pharmacognosy - Medicinal Plants
18
[44] Yeo QM, Crutchley R, Cottreau 
J, Tucker A, Garey KW. Crofelemer, 
a novel antisecretory agent 
approved for the treatment of HIV-
associated diarrhea. Drugs Today. 
2013;49:239-252. DOI: 10.1358/
dot.2013.49.4.1947253
[45] Tradtrantip L, Namkung 
W, Verkman AS. Crofelemer, 
an antisecretory antidiarrheal 
proanthocyanidin oligomer extracted 
from Croton lechleri, targets two distinct 
intestinal chloride channels. Molecular 
Pharmacology. 2010;77:69-78. DOI: 
10.1124/mol.109.061051
[46] Simić A, Soković MD, Ristić M, 
Grujić-Jovanović S, Vukojević J, Marin 
PD. The chemical composition of 
some Lauraceae essential oils and their 
antifungal activities. Phytotherapy 
Research. 2004;18:713-717. DOI: 
10.1002/ptr.1516
[47] dos Santos ÉRQ, Maia CSF, Fontes 
Junior EA, Melo AS, Pinheiro BG, Maia 
JGS. Linalool-rich essential oils from 
the Amazon display antidepressant-
type effect in rodents. Journal of 
Ethnopharmacology. 2018;212:43-49. 
DOI: 10.1016/j.jep.2017.10.013
[48] Branch LC, da Silva MF. Folk 
medicine of Alter do Chao, Pará. Acta 
Amazonica. 1983;13:737-797. DOI: 
10.1590/1809-4392135737
[49] Huo M, Cui X, Xue J, Chi G, Gao 
R, Deng X, et al. Anti-inflammatory 
effects of linalool in RAW 264.7 
macrophages and lipopolysaccharide-
induced lung injury model. Journal 
of Surgical Research. 2013;180: 
e47-e54. DOI: 10.1016/j.jss. 
2012.10.050
[50] Rodenak-Kladniew B, Castro A, 
Stärkel P, De Saeger C, García de Bravo 
M, Crespo R. Linalool induces cell cycle 
arrest and apoptosis in HepG2 cells 
through oxidative stress generation 
and modulation of Ras/MAPK and 
Akt/mTOR pathways. Life Sciences. 
2018;199:48-59. DOI: 10.1016/j.
lfs.2018.03.006
[51] Gu Y, Ting Z, Qiu X, Zhang X, Gan 
X, Fang Y, et al. Linalool preferentially 
induces robust apoptosis of a variety 
of leukemia cells via upregulating p53 
and cyclin-dependent kinase inhibitors. 
Toxicology. 2010;268:19-24. DOI: 
10.1016/j.tox.2009.11.013
[52] Shen Y-L, Wang T-Y, Chen T-Y, 
Chang M-Y. The proliferative inhibitor 
and apoptosis mechanism of linalool 
in breast cancer cells. Biomarkers and 
Genomic Medicine. 2013;5:131. DOI: 
10.1016/j.bgm.2013.08.016
[53] Pereira I, Severino P, Santos 
AC, Silva AM, Souto EB. Linalool 
bioactive properties and potential 
applicability in drug delivery systems. 
Colloids and Surfaces B: Biointerfaces. 
2018;171:566-578. DOI: 10.1016/j.
colsurfb.2018.08.001
[54] Kohn LK, Queiroga CL, Martini 
MC, Barata LE, Porto PSS, Souza 
L, et al. In vitro antiviral activity of 
Brazilian plants (Maytenus ilicifolia 
and Aniba rosaeodora) against 
bovine herpesvirus type 5 and avian 
metapneumovirus. Pharmaceutical 
Biology. 2012;50:1269-1275. DOI: 
10.3109/13880209.2012.673627
[55] Jabir MS, Taha AA, Sahib UI. 
Linalool loaded on glutathione 
modified gold nanoparticles: A drug 
delivery system for a successful 
antimicrobial therapy. Artificial Cells, 
Nanomedicine, and Biotechnology. 
2018;46:1-11. DOI:10.1080/21691401.20
18.1457535
[56] Ferreira GLS, Bezerra LMD, 
Ribeiro ILA, Morais Júnior RCD, 
Castro RD. Susceptibility of 
cariogenic microorganisms to 
phytoconstituents. Brazilian Journal 
of Biology. 2018;78:691-696. DOI: 
10.1590/1519-6984.174147
19
Medicinal Plants of the Peruvian Amazon: Bioactive Phytochemicals, Mechanisms of Action…
DOI: http://dx.doi.org/10.5772/intechopen.82461
[57] Sarrazin SLF, Oliveira RB, Maia JGS, 
Mourão RHV. Antibacterial activity of 
the rosewood (Aniba rosaeodora and A. 
parviflora) linalool-rich oils from the 
Amazon. European Journal of Medicinal 
Plants. 2015;12:1-9
[58] Pimentel RBQ, Souza DP, 
Albuquerque PM, Fernandes 
AV, Santos AS, Duvoisin S, et al. 
Variability and antifungal activity 
of volatile compounds from Aniba 
rosaeodora Ducke, harvested from 
Central Amazonia in two different 
seasons. Industrial Crops and 
Products. 2018;123:1-9. DOI: 10.1016/j.
indcrop.2018.06.055
[59] de Oliveira Lima MI, Araújo 
de Medeiros AC, Souza Silva KV, 
Cardoso GN, de Oliveira Lima E, de 
Oliveira Pereira F. Investigation of 
the antifungal potential of linalool 
against clinical isolates of fluconazole 
resistant Trichophyton rubrum. 
Journal de Mycologie Médicale. 
2017;27:195-202. DOI: 10.1016/j.
mycmed.2017.01.011
[60] VM V, Dubey VK, Ponnuraj K. 
Identification of two natural compound 
inhibitors of Leishmania donovani 
spermidine synthase (SpdS) through 
molecular docking and dynamic studies. 
Journal of Biomolecular Structure and 
Dynamics. 2018;36:2678-2693. DOI: 
10.1080/07391102.2017.1366947
[61] Dutra FL, Oliveira MM, Santos RS, 
Silva WS, Alviano DS, Vieira DP, et al. 
Effects of linalool and eugenol on the 
survival of Leishmania (L.) infantum 
chagasi within macrophages. Acta 
Tropica. 2016;164:69-76. DOI: 10.1016/j.
actatropica.2016.08.026
[62] García Prado E, García Gimenez 
MD, De la Puerta Vázquez R, 
Espartero Sánchez JL, Sáenz Rodríguez 
MT. Antiproliferative effects of 
mitraphylline, a pentacyclic oxindole 
alkaloid of Uncaria tomentosa on human 
glioma and neuroblastoma cell lines. 
Phytomedicine. 2007;14:280-284. DOI: 
10.1016/j.phymed.2006.12.023
[63] Reis SRIN, Valente LMM, Sampaio 
AL, Siani AC, Gandini M, Azeredo 
EL, et al. Immunomodulating and 
antiviral activities of Uncaria tomentosa 
on human monocytes infected 
with dengue virus-2. International 
Immunopharmacology. 2008;8:468-476. 
DOI: 10.1016/j.intimp.2007.11.010
[64] Sandoval-Chacón M, Thompson 
JH, Zhang XJ, Liu X, Mannick 
EE, Sadowska-Krowicka H, et al. 
Antiinflammatory actions of cat’s claw: 
The role of NF-kappaB. Alimentary 
Pharmacology & Therapeutics. 
1998;12:1279-1289
[65] Allen-Hall L, Arnason JT, Cano 
P, Lafrenie RM. Uncaria tomentosa 
acts as a potent TNF-alpha inhibitor 
through NF-kappaB. Journal of 
Ethnopharmacology. 2010;127:685-693. 
DOI: 10.1016/j.jep.2009.12.004
[66] Rojas-Duran R, González-Aspajo 
G, Ruiz-Martel C, Bourdy G, Doroteo-
Ortega VH, Alban-Castillo J, et al. Anti-
inflammatory activity of mitraphylline 
isolated from Uncaria tomentosa 
bark. Journal of Ethnopharmacology. 
2012;143:801-804. DOI: 10.1016/j.
jep.2012.07.015
[67] Montserrat-de la Paz S, de la 
Puerta R, Fernandez-Arche A, Quilez 
AM, Muriana FJG, Garcia-Gimenez 
MD, et al. Pharmacological effects of 
mitraphylline from Uncaria tomentosa 
in primary human monocytes: Skew 
toward M2 macrophages. Journal of 
Ethnopharmacology. 2015;170:128-135. 
DOI: 10.1016/j.jep.2015.05.002
[68] Fujita A, Sarkar D, Wu S, Kennelly 
E, Shetty K, Genovese MI. Evaluation 
of phenolic-linked bioactives of camu-
camu (Myrciaria dubia mc. Vaugh) for 
antihyperglycemia, antihypertension, 
Pharmacognosy - Medicinal Plants
20
antimicrobial properties and 
cellular rejuvenation. Food Research 
International. 2015;77:194-203. DOI: 
10.1016/j.foodres.2015.07.009
[69] Tauchen J, Bortl L, Huml L, 
Miksatkova P, Doskocil I, Marsik P, 
et al. Phenolic composition, antioxidant 
and anti-proliferative activities of 
edible and medicinal plants from the 
Peruvian Amazon. Revista Brasileira de 
Farmacognosia. 2016;26:728-737. DOI: 
10.1016/j.bjp.2016.03.016
[70] dos Santos AE, Kuster RM, 
Yamamoto KA, Salles TS, Campos 
R, de Meneses MD, et al. Quercetin 
and quercetin 3-O-glycosides from 
Bauhinia longifolia (bong.) Steud. 
show anti-Mayaro virus activity. 
Parasites & Vectors. 2014;7:130. DOI: 
10.1186/1756-3305-7-130
[71] D’Andrea G. Quercetin: A 
flavonol with multifaceted therapeutic 
applications? Fitoterapia. 2015;106: 
256-271. DOI: 10.1016/j.fitote.2015. 
09.018
[72] Wang W, Sun C, Mao L, Ma P, Liu 
F, Yang J, et al. The biological activities, 
chemical stability, metabolism and 
delivery systems of quercetin: A review. 
Trends in Food Science & Technology. 
2016;56:21-38. DOI: 10.1016/j.
tifs.2016.07.004
[73] Dajas F. Life or death: 
Neuroprotective and anticancer 
effects of quercetin. Journal of 
Ethnopharmacology. 2012;143:383-396. 
DOI: 10.1016/j.jep.2012.07.005
[74] Lesjak M, Beara I, Simin N, 
Pintać D, Majkić T, Bekvalac K, et al. 
Antioxidant and anti-inflammatory 
activities of quercetin and its 
derivatives. Journal of Functional 
Foods. 2018;40:68-75. DOI: 10.1016/j.
jff.2017.10.047
[75] Suganthy N, Devi KP, Nabavi 
SF, Braidy N, Nabavi SM. Bioactive 
effects of quercetin in the central 
nervous system: Focusing on the 
mechanisms of actions. Biomedicine 
& Pharmacotherapy. 2016;84:892-908. 
DOI: 10.1016/j.biopha.2016.10.011
[76] Patel RV, Mistry BM, Shinde SK, 
Syed R, Singh V, Shin H-S. Therapeutic 
potential of quercetin as a 
cardiovascular agent. European Journal 
of Medicinal Chemistry. 2018;155:889-
904. DOI: 10.1016/j.ejmech.2018.06.053
[77] Davies SP, Reddy H, Caivano M, 
Cohen P. Specificity and mechanism of 
action of some commonly used protein 
kinase inhibitors. Biochemical Journal. 
2000;351:95-105. DOI: 10.1042/bj3510095
[78] Cao H, Pauff JM, Hille R. X-ray crystal 
structure of a xanthine oxidase complex 
with the flavonoid inhibitor quercetin. 
Journal of Natural Products. 2014;77:1693-
1699. DOI: 10.1021/np500320g
[79] Zhang C, Wang R, Zhang G, 
Gong D. Mechanistic insights into 
the inhibition of quercetin on 
xanthine oxidase. International 
Journal of Biological Macromolecules. 
2018;112:405-412. DOI: 10.1016/j.
ijbiomac.2018.01.190
[80] Hamilton KE, Rekman JF, Gunnink 
LK, Busscher BM, Scott JL, Tidball 
AM, et al. Quercetin inhibits glucose 
transport by binding to an exofacial site 
on GLUT1. Biochimie. 2018;151:107-114. 
DOI: 10.1016/j.biochi.2018.05.012
[81] Sicheri F, Moarefi I, Kuriyan 
J. Crystal structure of the Src 
family tyrosine kinase Hck. Nature. 
1997;385:602-609. DOI: 10.1038/ 
385602a0
[82] Ugochukwu E, Soundararajan M, 
Rellos P, Fedorov O, Phillips C, Wang 
J, et al. Crystal Structure of Human 
Serine/Threonine Kinase 17B (STK17B) 
in Complex with Quercetin. RCSB PDB 
Protein Data Bank. 2010. DOI: 10.2210/
pdb3lm5/pdb
21
Medicinal Plants of the Peruvian Amazon: Bioactive Phytochemicals, Mechanisms of Action…
DOI: http://dx.doi.org/10.5772/intechopen.82461
[83] Walker EH, Pacold ME, Perisic 
O, Stephens L, Hawkins PT, Wymann 
MP, et al. Structural determinants of 
phosphoinositide 3-kinase inhibition 
by wortmannin, LY294002, quercetin, 
myricetin, and staurosporine. Molecular 
Cell. 2000;6:909-919
[84] Vaisberg AJ, Milla M, Planas 
MC, Cordova JL, de Agusti ER, 
Ferreyra R, et al. Taspine is the 
cicatrizant principle in Sangre de 
Grado extracted from Croton lechleri. 
Planta Medica. 1989;55:140-143. DOI: 
10.1055/s-2006-961907
[85] Porras-Reyes BH, Lewis WH, 
Roman J, Simchowitz L, Mustoe TA. 
Enhancement of wound healing by the 
alkaloid taspine defining mechanism of 
action. Proceedings of the Society for 
Experimental Biology and Medicine. 
1993;203:18-25
[86] Fayad W, Fryknäs M, Brnjic 
S, Olofsson MH, Larsson R, 
Linder S. Identification of a novel 
topoisomerase inhibitor effective in cells 
overexpressing drug efflux transporters. 
PLoS One. 2009;4:e7238. DOI: 10.1371/
journal.pone.0007238
[87] Zhan Y, Zhang Y, Chen Y, Wang 
N, Zheng L, He L. Activity of taspine 
isolated from radix et Rhizoma Leonticis 
against estrogen-receptor-positive 
breast cancer. Fitoterapia. 2011;82:896-
902. DOI: 10.1016/j.fitote.2011.05.004
[88] Castelli S, Katkar P, Vassallo O, 
Falconi M, Linder S, Desideri A. A 
natural anticancer agent thaspine 
targets human topoisomerase IB. Anti-
Cancer Agents in Medicinal Chemistry. 
2013;13:356-363
[89] Jako C, Coutu C, Roewer I, Reed 
DW, Pelcher LE, Covello PS. Probing 
carotenoid biosynthesis in developing 
seed coats of Bixa orellana (Bixaceae) 
through expressed sequence tag analysis. 
Plant Science. 2002;163:141-145. DOI: 
10.1016/S0168-9452(02)00083-3
[90] Cárdenas-Conejo Y, Carballo-Uicab 
V, Lieberman M, Aguilar-Espinosa M, 
Comai L, Rivera-Madrid R. De novo 
transcriptome sequencing in Bixa 
orellana to identify genes involved 
in methylerythritol phosphate, 
carotenoid and bixin biosynthesis. BMC 
Genomics. 2015;16:877. DOI: 10.1186/
s12864-015-2065-4
[91] Bouvier F, Dogbo O, Camara 
B. Biosynthesis of the food and cosmetic 
plant pigment bixin (annatto). Science. 
2003;300:2089-2091. DOI: 10.1126/
science.1085162
[92] Dubey VS, Bhalla R, Luthra R. An 
overview of the non-mevalonate 
pathway for terpenoid biosynthesis 
in plants. Journal of Biosciences. 
2003;28:637. DOI: 10.1007/BF02703339
[93] Rohmer M. The discovery of a 
mevalonate-independent pathway for 
isoprenoid biosynthesis in bacteria, 
algae and higher plants. Natural Product 
Reports. 1999;16:565-574
[94] Zhu B-Q, Cai J, Wang Z-Q, 
Xu X-Q, Duan C-Q, Pan Q-H, 
et al. Identification of a plastid-
localized bifunctional nerolidol/
linalool synthase in relation to 
linalool biosynthesis in young 
grape berries. International 
Journal of Molecular Sciences. 
2014;15:21992-22010. DOI: 10.3390/
ijms151221992
[95] Lichtenthaler HK, Schwender J,  
Disch A, Rohmer M. Biosynthesis 
of isoprenoids in higher plant 
chloroplasts proceeds via a mevalonate-
independent pathway. FEBS Letters. 
1997;400:271-274. DOI: 10.1016/
S0014-5793(96)01404-4
[96] Suga T, Shishibori T, Bukeo 
M. Biosynthesis of linalool in 
higher plants. Phytochemistry. 
1971;10:2725-2726. DOI: 10.1016/
S0031-9422(00)97272-8
Pharmacognosy - Medicinal Plants
22
[97] Chen C, Zheng Y, Zhong Y, Wu Y, Li 
Z, Xu L-A, et al. Transcriptome analysis 
and identification of genes related to 
terpenoid biosynthesis in Cinnamomum 
camphora. BMC Genomics. 2018;19:550. 
DOI: 10.1186/s12864-018-4941-1
[98] Okada K, Kasahara H, Yamaguchi 
S, Kawaide H, Kamiya Y, Nojiri H, 
et al. Genetic evidence for the role of 
isopentenyl diphosphate isomerases 
in the mevalonate pathway and plant 
development in Arabidopsis. Plant and 
Cell Physiology. 2008;49:604-616. DOI: 
10.1093/pcp/pcn032
[99] Neti SS, Pan J-J, Poulter CD.  
Mechanistic studies of the 
protonation-deprotonation reactions 
for type 1 and type 2 isopentenyl 
diphosphate:dimethylallyl diphosphate 
isomerase. Journal of the American 
Chemical Society. 2018;140:12900-
12908. DOI: 10.1021/jacs.8b07274
[100] Falcone Ferreyra ML, Rius SP, 
Casati P. Flavonoids: Biosynthesis, 
biological functions, and 
biotechnological applications. Frontiers 
in Plant Science. 2012;3:222. DOI: 
10.3389/fpls.2012.00222
[101] Cheynier V, Comte G, Davies KM, 
Lattanzio V, Martens S. Plant phenolics: 
Recent advances on their biosynthesis, 
genetics, and ecophysiology. Plant 
Physiology and Biochemistry. 2013;72: 
1-20. DOI: 10.1016/j.plaphy.2013.05.009
